CRISPR/Cas9‑mediated cervical cancer treatment targeting human papillomavirus E6

Takahiro Yoshiba(Jichi Medical University), Hiroaki Mizukami(Jichi Medical University)
Oncology Letters
December 10, 2018
10.3892/ol.2018.9815
Cited by 108

Related Papers

Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16�E6/E7
|International Journal of Oncology|2018|25
Adeno-associated virus vector system controlling capsid expression improves viral quantity and quality
|iScience|2023|13